StockWatch
·
Biotechnology: Pharmaceutical Preparations
Loan & DebtAug 12, 2026, 09:32 AM

Alkermes Reduces Interest Rates on $1.5B Term Loan Facilities

AI Summary

Alkermes plc has amended its Credit Agreement, resulting in a reduction of interest rate spreads on its senior secured term loan A (TLA) and term loan B (TLB) facilities. The TLA Facility's spread was cut by 0.75%, and the TLB Facility's by 0.50%. This amendment also refinances the existing $773.06 million TLB Facility, maintaining the principal amount while lowering borrowing costs for the company.

Key Highlights

  • Alkermes plc entered into Amendment No. 1 to its Credit Agreement on August 12, 2026.
  • The senior secured term loan A (TLA) Facility has an outstanding principal of $745,312,500.
  • The senior secured term loan B (TLB) Facility has an outstanding principal of $773,062,500.
  • The interest rate spread for the TLA Facility was reduced by 0.75%.
  • The interest rate spread for the TLB Facility was reduced by 0.50%.
  • The TLA Facility matures on February 12, 2031, and the TLB Facility matures on August 12, 2031.
  • The TLB Facility is being refinanced with 2026 Refinancing Tranche B Term Loans.